Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Affiliations Topics Sessions Videos Audios Previous meetings

Topics

Select Topic

Showing 230 results for "Acute Myeloid Leukemia (AML)".

Thumbnail for Oral Azacitidine Maintenance vs Observation in Acute Myeloid Leukemia in First Remission: A Systematic Review and Pooled Analysis of Randomized Evidence

AML - 301

Oral Azacitidine Maintenance vs Observation in Acute Myeloid Leukemia in First Remission: A Systematic Review and Pooled Analysis of Randomized Evidence

Elias Tayar

Poster Presenter: Elias Tayar

Thumbnail for Steroid-Associated Toxicities and Survival Outcomes in Acute Promyelocytic Leukemia Treated With ATO/ATRA With or Without Chemotherapy

AML - 327

Steroid-Associated Toxicities and Survival Outcomes in Acute Promyelocytic Leukemia Treated With ATO/ATRA With or Without Chemotherapy

Gautam Pantwalawalkar

Poster Presenter: Gautam Pantwalawalkar

Previous 1...13 14 15 16 17 18 19...26 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

Thumbnail for Widening Racial and Urban-Rural Disparities in AML Mortality in the Targeted Therapy Era: A Population-Level Analysis of US Mortality Trends, 2018-2024

AML - 336

Widening Racial and Urban-Rural Disparities in AML Mortality in the Targeted Therapy Era: A Population-Level Analysis of US Mortality Trends, 2018-2024

Tapan Giri

Poster Presenter: Tapan Giri

Thumbnail for MYELOVAC: A Phase 1 Trial of a Personalized Peptide-Based Neoantigen Vaccination Platform in Combination With Hypomethylating Agent-Based Therapy for Patients With Acute Myeloid Leukemia in First Complete Remission Ineligible for Intensive Chemotherapy and Allogeneic Stem Cell Transplantation

AML - 347

MYELOVAC: A Phase 1 Trial of a Personalized Peptide-Based Neoantigen Vaccination Platform in Combination With Hypomethylating Agent-Based Therapy for Patients With Acute Myeloid Leukemia in First Complete Remission Ineligible for Intensive Chemotherapy and Allogeneic Stem Cell Transplantation

Nikolaos Spyrou

Poster Presenter: Nikolaos Spyrou

Thumbnail for Suicide Mortality Among Hematological Malignancy Survivors: A Population-Based SEER-CDC analysis

AML - 350

Suicide Mortality Among Hematological Malignancy Survivors: A Population-Based SEER-CDC analysis

Vidushi Reddy Gillela

Poster Presenter: Vidushi Reddy Gillela

Thumbnail for Therapy-Related Myeloid Neoplasms After Radioactive Iodine in Thyroid Cancer: A Scoping Review

AML - 357

Therapy-Related Myeloid Neoplasms After Radioactive Iodine in Thyroid Cancer: A Scoping Review

Tareq Abuasab

Poster Presenter: Tareq Abuasab

Thumbnail for Mortality Trends and Disparities Due to Acute Myeloid Leukemia Coexisting With Agranulocytosis: A 26-Year CDC WONDER Analysis From 1999 to 2024

AML - 372

Mortality Trends and Disparities Due to Acute Myeloid Leukemia Coexisting With Agranulocytosis: A 26-Year CDC WONDER Analysis From 1999 to 2024

Fnu Sumia

Poster Presenter: Fnu Sumia

Thumbnail for Lineage-Specific CK2a Deletion Reshapes the Transcriptome of Hematopoietic Stem Cells Toward an Immune-Primed State

AML - 377

Lineage-Specific CK2a Deletion Reshapes the Transcriptome of Hematopoietic Stem Cells Toward an Immune-Primed State

Yasin Uzun

Poster Presenter: Yasin Uzun

Thumbnail for Venetoclax in Combination With a Hypomethylating Agent for Patients With Newly Diagnosed Acute Myeloid Leukemia Who Are Medically Unfit for Intensive Induction Therapy: A Real-World Community Experience

AML - 384

Venetoclax in Combination With a Hypomethylating Agent for Patients With Newly Diagnosed Acute Myeloid Leukemia Who Are Medically Unfit for Intensive Induction Therapy: A Real-World Community Experience

Chiara Perni

Poster Presenter: Chiara Perni

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors